Clinical Trial Update: Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating apalutamide with radiotherapy and androgen deprivation therapy in prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 3 | Status: WITHDRAWN